This document discusses potential future treatments for diabetes using stem cells and gene therapy. It outlines the limitations of using mature B-cells as a treatment source and describes the developmental stages of beta cells. Gene therapy involves preparing genetic material and a delivery system. Non-embryonic stem cell sources include adult bone marrow, umbilical cord cells, and amniotic fluid cells. Induced pluripotent stem cells can be created by reprogramming adult cells back to a stem cell state. Recent research focuses on using mesenchymal stem cells for their anti-inflammatory and immune-suppressive properties to protect pancreatic beta cells from immune destruction in type 1 diabetes.